ATHIRA PHARMA INC. - COMMON STOCK
0.4443
27-九月-24 15:59:55
15 分钟延时
股票
+0.0257
+6.14%
今日范围
0.4250 - 0.4465
ISIN
N/A
来源
NASDAQ
-
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
17 9月 2024 09:00:00 条件 Nasdaq GlobeNewswire
-
03 9月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
01 8月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
09 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
12 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
11 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Upcoming June Conferences
29 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
17 5月 2024 17:00:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
15 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Upcoming May Conferences
02 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
15 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
11 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
03 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
22 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
08 2月 2024 16:02:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
08 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
03 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
12 12月 2023 07:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >